Understanding Public Attitudes Towards the COVID-19 Vaccination (CEAL)

University of Massachusetts, Worcester

Status: Withdrawn

Conditions: Vaccination; Covid19

Treatments: Behavioral: Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT05023512

H00023672

1OT2HL156812-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The objective of this study is to better understand public attitudes towards coronavirus disease 2019 (COVID-19) vaccination. This understanding will inform the development of community engagement strategies to be used in future interventions and studies aimed at addressing factors that impact the disproportionate burden of COVID-19 in under-served and vulnerable communities.

Full description

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly instigated a global pandemic. As of this writing, there are more than 33 million documented cases of infection in the United States (US). Furthermore, in the US, COVID-19 has disrupted the economy, overwhelmed the healthcare system, led to widespread school cancellations, and caused more than 595,000 deaths since March 2020.

The availability of three highly effective vaccines against COVID-19 within a year of the start of the pandemic is an extraordinary achievement and cause for great optimism. However, a significant proportion of adults in the U.S. have not accepted vaccination against COVID-19. Efforts are needed to identify effective messages and communication strategies to overcome COVID-19 vaccine hesitancy.

To address this need, the investigators plan to conduct two rapid surveys among Massachusetts residents, to assess attitudes towards COVID-19 vaccination.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Massachusetts resident
• Adult (age 18 and over)
• English or Spanish speaking

Exclusion criteria

• Non-English or Spanish speaking

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

Message 1

Experimental group

Description:

Participants will be randomized to receive version #1 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.

Treatment:

Behavioral: Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health

Message 2

Experimental group

Description:

Participants will be randomized to receive version #2 of 2 different versions of a message from the Massachusetts Department of Public Health regarding the COVID-19 vaccination.

Treatment:

Behavioral: Communication about the COVID-19 vaccination from the Massachusetts Department of Public Health